Pancreatic Cancer Information Center
Each year in the United States, more than 37,000 people are diagnosed with pancreatic cancer. Pancreatic cancer is often detected at an advanced stage when it is difficult to treat, highlighting the importance of research on prevention and early detection.
Although long-term survival with pancreatic cancer remains poor, researchers continue to explore new approaches to treatment. In addition, advances in supportive care have made pancreatic cancer treatment more tolerable, leading to improved quality of life.
Understanding pancreatic cancer treatment options, the role of different doctors specializing in the treatment of pancreatic cancer, and how and when to access new and innovative pancreatic cancer treatment options available through clinical trials is essential in order to achieve the best outcome from pancreatic cancer treatment.
The Cancer Consultants Pancreatic Cancer Information Center has been designed to help patients understand pancreatic cancer and pancreatic cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of pancreatic cancer.
Headline Pancreatic Cancer News 
Excess Weight Linked with More Than 100,000 Cancer Diagnoses Each Year
Increases risk of several types of cancer
November Is National Pancreatic Cancer Awareness Month
Learn more about this often late-detected disease.
Lynch Syndrome Increases Risk of Pancreatic Cancer
Risk is eight times higher than in general population.
Pancreatic Cancer Tips
Managing a rare cancer One survivor shares her tips for navigating the sometimes...
Sun Safety During Cancer Treatment Shielding your skin from the sun’s potentially harmful ultraviolet rays...
Understanding the Goals of Cancer Treatment with Chemotherapy If you’ve been diagnosed with cancer, your healthcare team may have prescribed...
Pancreatic Cancer Management
Inspiration, Hope & Resources
Pancreatic Cancer Action Network By Diana Price Julie Fleshman knows all about the urgent need for hope that grips...
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Pancreatic Cancer Clinical Trials
INST0802 – Phase II Trial of Combination Irinotecan, Oxaliplatin and Cetuximab for Patients with Locally Advanced or Metastatic Pancreatic Cancer
07-111 – A Phase II randomized, double-blind, multicenter trial of Amplimexon plus Gemcitabine versus Gemcitabine plus placebo in patients with metastatic chemotherapy naive pancreatic adenocarcinoma.
MORAb-009 – A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of MORAb-009 in Conmbination with Gemcitabine in Patients with Advanced Pancreatic Cancer
 |
 |
 |
 |
